New United Nations data about gains made in the fight against HIV/AIDS is sparking optimism ahead of the 2012 International AIDS Conference in Washington. But countries most affected by the pandemic still struggle to place enough people on treatment and to implement the best science and strategies to fight the disease, Médecins Sans Frontières (MSF) warned today. As leaders and scientists prepare to discuss the latest initiatives needed to scale up treatment to such a high level it could potentially end the epidemic, seven million people still require urgent access to antiretroviral (ARV) treatment. While the United Nations AIDS agency (UNAIDS) estimates that 1.4 million more people were put on antiretroviral therapy in 2011, this pace will have to double to reach the global goal of 15 million people receiving treatment by 2015. At the same time, international discourse is increasingly urging Africans to find their own domestic solutions to the HIV emergency. African states cannot combat HIV alone “It would be outrageous to assume that African states could combat this emergency alone, given their current limited resources,” said Dr Eric Goemaere, MSF’s HIV/AIDS senior regional advisor for southern Africa. “This is just a cynical excuse for donors to scale back on their earlier commitments of putting an end to this disease. It will have catastrophic consequences for patients.” In the Democratic Republic of the Congo (DRC), less than 15 per cent of patients who need ARV therapy receive it, 11 per cent of health facilities offer treatment, and less than 6 per cent of HIV-positive mothers have access to ARV drugs to prevent their children from becoming infected. “We receive critically ill patients who have desperately searched for ARV treatment,” said Thierry Dethier, MSF’s advocacy manager in DRC. “For too many, their disease has progressed so far that they are literally dying on our doorstep.” International support stagnates Several governments have taken important and courageous steps to address the HIV pandemic. Zimbabwe and Malawi have made major progress in broadening treatment programs in recent years. Malawi was the first country in Africa to implement prevention of mother-to-child transmission protocols, which foresee lifelong treatment for HIV-positive expectant or lactating mothers. Mozambique recently recommended a similar protocol, prescribing better first-line treatment and monitoring treatment progress by using viral load testing. Yet, plans for scaling up treatment and improving quality of care risk being scrapped entirely as international support stagnates, with donors turning a blind eye to their earlier commitments. Important institutions in fighting the pandemic like the Global Fund are facing major funding shortfalls due to waning donor interest. “In Malawi we’re committed to implementing programmes based on recent scientific progress,” said Stuart Chuka, national ARV treatment programme officer from the Malawi Ministry of Health. “Yet just as success is within reach, we’re up against a great financial squeeze. I truly believe that we can end AIDS. But we can’t do it alone.” From: MSF
GMT 18:35 2018 Thursday ,11 January
Syrian refugee sets himself ablaze at UN office in LebanonGMT 18:48 2018 Tuesday ,09 January
Novo Nordisk woos Belgian nano-drug makerGMT 17:54 2017 Wednesday ,27 December
Medical evacuations begin from besieged Syria rebel bastionGMT 12:14 2017 Monday ,25 December
MoHAP successfully conducts cochlear implant operationGMT 18:24 2017 Sunday ,24 December
Palestinian conjoined twins arrive in RiyadhGMT 19:05 2017 Monday ,18 December
new! magazine names fitness & food editorGMT 17:03 2017 Wednesday ,29 November
Spain reports case of 'mad cow disease'GMT 14:05 2017 Saturday ,11 November
EU can't agree on new licence for controversial glyphosate weedkiller
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Send your comments
Your comment as a visitor